MAPT and Alzheimer disease: Although no animal model perfectly reproduces AD sequelae, EFAD mice are advantageous in that they model late-onset APOE-related AD risk in a mouse with established hippocampal and neocortical amyloid deposition, tau hyperphosphorylation, and synaptic degeneration typical of AD.